The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...
A small change to a powerful molecular tool developed by Princeton researchers could help scientists detect disease faster and with greater accuracy. Researchers at Princeton University are developing ...
This is a preview. Log in through your library . Abstract Type VI CRISPR-Cas systems have been repurposed for various applications such as gene knockdown, viral interference, and diagnostics. However, ...
Scientists at the Korea Advanced Institute of Science and Technology (KAIST), in collaboration with researchers at the ...
< Photo 1. (From left) Professor Won Do Heo and Jihwan Yu, a Ph.D. Candidate of the Department of Biological Sciences > CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age ...
Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat ...
The CRISPR gene editing technology has transformed the research lab, and this powerful tool is now making its way into the clinic. So far, three different human diseases have been successfully treated ...
The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nucleases. In contrast, ...